Recently added item(s)
You have no items in your basket.
The female body is a complex system of several hormones working in synergy to regulate physiology, behaviour, and the ability to thrive and reproduce. Hormone balance is a cornerstone of women’s health. Unfortunately, maintaining this natural balance has never been more difficult due to the modern environment we live in and our busy lifestyles. One of the main hormones that is directly impacted by this is oestrogen.
Oestrogen is one of the main sex hormones, produced by women, which is responsible for a number of functions, from regulating menstrual cycles to maintaining bone density,[i] regulating fat stores,[ii] and supporting learning and memory.[iii]
There are three types of oestrogen: oestradiol (most potent and predominant in reproductive years), oestrone (predominant during and after the menopause[iv]), and oestriol (present in large amounts during pregnancy[v]). Through oestrogen metabolism, we also produce different metabolites, some of which can be harmful.
Some women might experience symptoms of ‘oestrogen dominance’, commonly understood as having too much oestrogen in the body. We see it as a state of excessive oestrogenic activity which can involve any or all of the following factors:
Essentially, you could imagine it as a funnel; if we have a lot of oestrogen floating around whilst our body is unhealthy and unable to detoxify effectively, we end up with too much oestrogen, or the wrong types of metabolites.
This can then lead to various symptoms and conditions, including:
In addition to the above recommendations, here are a few resources to get you started:
The brand you can talk to:
Not registered for an account with BioCare®?
[i] Cauley JA. Estrogen and bone health in men and women. Steroids. 2015; 99:11-5
[ii] Kim JH et al. The role of estrogen in adipose tissue metabolism: insights into glucose homeostasis regulation. Endocrin J. 2014; 61(11):1055-67
[iii] Barth C, Villringer A, Sacher J. Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods. Front Neurosci. 2015; 9: 37.
[iv] Rannevik et al. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas. 1995; 21 (2): 103-13.
[v] Mucci LA et al. Pregnancy estriol, estradiol, progesterone and prolaction in relation to birth weight and other birth size variables (United States). Cancer Causes Control 2003;14:311–8.
[vi] Fulghesu AM et al. The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome. J Clin Endocrinol Metab. 1997; 82 (2): 644-8.
[vii] Williams G. Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant ER-α and GPER signalling. Mol Cell Endocrinol. 2012;351(2):269-78
[viii] McTernan PG et al. Gender differences in the regulation of P450 aromatase expression and activity in human adipose tissue. International Journal of Obesity. 2000; 24:875-881
[ix] Nagata C et al. Light exposure at night, urinary 6-sulfatoxymelatonin and serum estrogens and androgens in postmenopausal Japanese women. Cancer Epidemiol Bio Prev. 2008; 17 (6).
[x] Krishnan AV et al. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology. 1993;132:2279–86.
[xi] Sheikh IA et al. Endocrine disruption: computational perspectives on human sex hormone-binding globulin and phthalate plasticizers. PLoS One. 2016; 11 (3): e0151444.
[xii]Wang J et al. Recent Advances on Endocrine Disrupting Effects of UV Filters. Hong H, ed. International Journal of Environmental Research and Public Health. 2016;13(8):782.
[xiii] Schmidt PJ et al. Differential behavioural effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med. 1998; 338(4):209-16
[xiv] Stachenfeld NS. Sex Hormone Effects on Body Fluid Regulation. Exercise and sport sciences reviews. 2008;36(3):152-159.
[xv] Bulun SE. Uterine Fibroids. N Engl J Med. 2013; 369(14): 1344-55
[xvi] Vercellini P et al. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014; 10(5): 261-75
[xvii] Wypych K, Kuźlik R, Wypych P. [Hormonal abnormalities in women with breast cysts]. Ginekol Pol. 2002 Nov;73(11):1117-25.
[xviii] Borsook D et al. Sex and the migraine brain. Neurobiol Dis. 2014; 68:200-14
[xix] Darbre PD, Harvey PW. Parabens can enable hallmarks and characteristics of cancer in human breast epithelial cells: a review of the literature with reference to new exposure data and regulatory status. J Appl Toxicol. 2014;34:925–38.
[xx] Déchaud H et al. Xenoestrogen interaction with human sex hormone-binding globulin (hSHBG). Steroids. 1999 May;64(5):328-34.
[xxi] Shanle EK, Xu W. Endocrine disrupting chemicals targeting estrogen receptor signaling: Identification and mechanisms of action. Chemical research in toxicology. 2011;24(1):6-19.
[xxii] Envtl. Working Grp., Exposures Add Up- Survey Results (2004), http://www.ewg.org/skindeep/2004/06/15/exposures-a...
[xxiii] Krishnan AV et al. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology. 1993;132:2279–86.
[xxiv] Bittner et al. Estrogenic chemicals often leach from BPA-free plastic products that are replacements for BPA-containing polycarbonate products. Environmental Health. 2014;13:41
[xxv] Molina-Molina et al. Determination of bisphenol A and bisphenol S concentrations and assessment of estrogen- and anti-androgen-like activities in thermal paper receipts from Brazil, France, and Spain. Environmental Research. 2019;170:406-415
[xxvi] Ehrlich et al. Handling of Thermal Receipts as a Source of Exposure to Bisphenol A. JAMA, 2014; 311 (8): 859.
[xxvii] Ennour-Idrissi et al. Effect of physical activity on sex hormones in women: a systematic review and meta-analysis of randomized controlled trials. Breast Cancer Research. 2015;17:139.
[xxviii] McTernan PG et al. Gender differences in the regulation of P450 aromatase expression and activity in human adipose tissue. International Journal of Obesity. 2000; 24:875-881
[xxix] Rinaldi S et al. Relationship of alcohol intake and sex steroid concentrations in blood in pre- and post-menopausal women: the European Prospective Investigation into Cancer and Nutrition. Cancer Causes Control. 2006;17(8):1033-43.
[xxx] Breatveld et al. Pesticide exposure: the hormonal function of the female reproductive system disrupted? Reproductive Biology and Endocrinology. 2006;4:30
[xxxi] Cassidy. Potential tissue selectivity of dietary phytooestrogens and oestrogens. Curr Opin Lipidol 1999;10:47-52.
[xxxii] Brzezinski et al. Phytooestrogens: the "natural" selective oestrogen receptor modulators? Eur J Obstet Gynecol 1999;85:47-51.
[xxxiii] Heiss E al. Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J Biol Chem 2001;276:32008-15.
[xxxiv] Tully et al. Modulation of steroid receptor-mediated gene expression by vitamin B6. FASEB J 1994;8(3):343-49.
[xxxv] Wyatt et al. (1999) Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. British Medical Journal, 318, 1375.
[xxxvi] Quaranta et al. Pilot study of the efficacy and safety of a modified-release magnesium 250 mg tablet (Sincromag) for the treatment of premenstrual syndrome. Clin Drug Investig. 2007; 27 (1): 51-8.
[xxxvii] Reed GA, et al. A phase I study of indole-3-carbinol in women: tolerability and effects. Cancer Epidemiol Biomarkers Prev. 2005;14(8):1953-60.
[xxxviii] Cho H-J, et al. Pharmacokinetic Interactions of Herbs with Cytochrome P450 and P-Glycoprotein. Evidence-based Complementary and Alternative Medicine : eCAM. 2015; 2015:736431
[xxxix] Kao et al. Endocrinology 141: 980–987, 2000
[xl] Cassidy. Potential tissue selectivity of dietary phytooestrogens and oestrogens. Curr Opin Lipidol 1999;10:47-52.
[xli] Brzezinski et al. Phytooestrogens: the "natural" selective oestrogen receptor modulators? Eur J Obstet Gynecol 1999;85:47-51.